Fisher & Paykel Healthcare Corporation Ltd

Price Chart

Risk-Adjusted Performance

Fisher & Paykel Healthcare Corporation Ltd (FPH) Price Performance

Fisher & Paykel Healthcare Corporation Ltd (FPH) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at AUD30.21, up 0.70% from the previous close.

Over the past year, FPH has traded between a low of AUD29.90 and a high of AUD34.70. The stock has lost 3.9% over this period. It is currently 12.9% below its 52-week high.

Fisher & Paykel Healthcare Corporation Ltd has a market capitalization of $18.75B, with a price-to-earnings ratio of 52.34 and a dividend yield of 1.37%.

About Fisher & Paykel Healthcare Corporation Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.